Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SIMULATIONS PLUS, INC.

(SLP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Simulations Plus, Inc.
Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. The Company offers its products and services through two business segments, which include Simulations Plus, Inc. and Cognigen Corporation. Cognigen Corporation is the subsidiary of the Company. Its pharmaceutical/chemistry software is used by various companies, such as pharmaceutical, biotechnology, agrochemical, and food industry companies and to regulatory agencies for use in the conduct of industry-based research. Its clinical-pharmacology-based consulting services include pharmacokinetic and pharmacodynamics modeling, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions.

Number of employees : 137 people.
Sales per Business
2020
Simulations Plus, Inc.21.9652.8%
Cognigen Corporation11.1126.7%
DILIsym6.9516.7%
Lixoft1.583.8%
USD in Million
Sales per region
2020
North & South America29.6771.4%
Asia6.0914.6%
Europe5.8314%
USD in Million
Managers
Name Title Age Since
Shawn M. O'Connor Chief Executive Officer 61 2018
William W. Frederick Chief Financial Officer & Secretary 57 2020
Viera Lukacova, Dr. Chief Scientist - -
David L. Ralph, Dr. Independent Director 73 2012
John Kenneth Paglia, Dr. Independent Director 53 2014
Daniel L. Weiner, Dr. Independent Director 70 2017
Lisa LaVange, Dr. Independent Director 67 2019
Renee Bouche Investor Relations Contact - -
John Anthony DiBella President-Lancaster Division 41 2017
Sandra Suarez-Sharp, Dr. Vice President-Regulatory Affairs - 2020
Members of the board
Name Title Age Since
Walter S. Woltosz Chairman 75 2018
David L. Ralph, Dr. Independent Director 73 2012
John Kenneth Paglia, Dr. Independent Director 53 2014
Daniel L. Weiner, Dr. Independent Director 70 2017
Lisa LaVange, Dr. Independent Director 67 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 20,132,906 15,586,159 77.4% 0 0.0% 77.4%
Shareholders
NameEquities%
Virginia E. Woltosz 4,480,112 22.3%
Neuberger Berman Investment Advisers LLC 1,220,163 6.07%
The Vanguard Group, Inc. 944,470 4.70%
Conestoga Capital Advisors LLC 722,985 3.59%
Ranger Investment Management LP 651,772 3.24%
SSgA Funds Management, Inc. 489,812 2.44%
BlackRock Fund Advisors 438,210 2.18%
Royce & Associates LP 409,068 2.03%
Montanaro Asset Management Ltd. 394,400 1.96%
Lazard Asset Management LLC 318,727 1.58%
Company contact information
Simulations Plus, Inc.
42505 10th Street West
Lancaster, CA 93534-7059

Phone : +1.661.723.7723
Web : http://www.simulations-plus.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Simulations Plus, Inc.